Aug 20 (Reuters) - Cytosorbents Corp CTSO.O:
CYTOSORBENTS UPDATES U.S. FDA REGULATORY STATUS OF DRUGSORB-ATR
CYTOSORBENTS CORP - FDA FINDS NO SAFETY ISSUES WITH DRUGSORB-ATR, UPHOLDS DENIAL
CYTOSORBENTS CORP - FDA PROPOSES PATH FORWARD FOR DRUGSORB-ATR MARKET AUTHORIZATION
CYTOSORBENTS CORP - FDA NOTES APPEAL AVENUE TO CDRH DIRECTOR WITHIN 30 DAYS
Source text: ID:nPn5ktnsta
Further company coverage: CTSO.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.